MiroBio
MiroBio is Harnessing the natural control mechanisms of the immune system.
MiroBio operates in biotechnology, life science based in Europe, Middle East, and Africa (EMEA), founded in 2019.
Its activity falls under biotechnology, life science; the profile below is assembled from public directory data.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_B stage of development.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $107M in funding.
| Sector | Biotechnology, Life Science |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $107,000,000 |
Website: www.mirobio.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account